FNO Stocks

Laurus Labs (NSE: LAURUSLABS) – Bullish Or Bearish Analysis ,Price Target

Live Share Price & Chart

You can view the live NSE chart here:

TradingView Live Chart:
https://www.tradingview.com/symbols/NSE-LAURUSLABS/

NSE Quote:
https://www.nseindia.com/get-quotes/equity?symbol=LAURUSLABS

Laurus Labs Bullish Or Bearish = Bullish

Laurus Labs Price Target In 2030 = 8000 above

Company Overview

Laurus Labs is one of India’s leading pharmaceutical manufacturers specializing in:

Active Pharmaceutical Ingredients (API)
Contract Development & Manufacturing (CDMO)
Generic Formulations
Biotechnology
Specialty Chemicals

The company exports to more than 80 countries and supplies major global pharmaceutical companies.

Option Traders (FNO Traders )

One of the momentum Stock in pharma Sector
For Option Traders Might Helpful the stock
If Stock Fallen On market Fall Then Buy Call option in 15 min Support
After Market Wake Laurus Surely going up Then Book The profits
Because The pharma Sector also Going Good in Upcoming Days

Fundamental Analysis

Particular	Details
Sector	Pharmaceuticals
Market Cap	₹80,000+ Crore
Business Model	API + CDMO + Formulations
ROE	Improving
ROCE	Strong improvement
Debt	Low
Cash Flow	Positive
Promoter Holding	Stable
Export Revenue	Around 60%+
Dividend	Low Yield

Recent revenue and earnings have grown strongly, supported by higher CDMO demand and improved operating leverage.

Strengths

✅ Strong CDMO order pipeline

✅ Global customer base

✅ USFDA-approved manufacturing facilities

✅ Healthy balance sheet

✅ Expansion into peptides and biologics

✅ Consistent capacity expansion

Risks

USFDA regulatory observations
Currency fluctuations
Pricing pressure in generic drugs
High valuation after recent rally
Pharma sector volatility

Growth Drivers

CDMO business expansion
Oncology APIs
Biotechnology segment
Peptide manufacturing
Export growth
Capacity expansion over the next two years

Management has announced significant capital expenditure focused on CDMO, peptides, fermentation and advanced therapies, which many analysts view as a long-term growth driver.

Financial Snapshot

Metric	View
Revenue Growth	⭐⭐⭐⭐⭐
Profit Growth	⭐⭐⭐⭐⭐
Debt	⭐⭐⭐⭐☆
Cash Flow	⭐⭐⭐⭐☆
Margin Expansion	⭐⭐⭐⭐⭐
Long-Term Growth	⭐⭐⭐⭐⭐

Technical View

Current Trend: Strong Bullish

Support Levels

₹1,350
₹1,250
₹1,150

Resistance Levels

₹1,500
₹1,650
₹1,800

A sustained move above ₹1,500 with strong volume could indicate further upside, while a break below ₹1,350 would weaken the short-term trend.

Price Target

Short Term (3–6 Months)

Target 1: 1,900
Target 2: 2500

Medium Term (12 Months)

Base Case: 3500
Bullish Case: 5,000

Overall View

Laurus Labs remains one of the stronger growth stories in the Indian pharmaceutical sector due to its expanding CDMO business, improving profitability, and ongoing investments in high-growth areas. However, after a sharp price rally, valuation has become richer, so staggered buying on market corrections may offer a better risk-reward profile than chasing the stock at new highs.

tirumedia